Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Company Profile Outlook Therapeutics Inc. OTLK

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.


Company Profile & Information (NDAQ:OTLK)

Showcase News Releases

Showcase news

Fandifi Technology Corp.
Fandifi Expands Beta Sign-Ups Under Elite Duels Partnership
Pan Global Resources Inc
Pan Global Reports Multiple High-Grade Polymetallic Drill Intercepts at the Aguilas Project, Spain
Fireweed Metals Corp.
BTV Presents Invest in Canada's North Featuring: Snowline Gold, North Arrow Minerals, Fireweed Metals, Gold Terra, & Strategic Metals

More Showcase News Releases »